TSS
HRTX icon

Two Sigma Securities’s Heron Therapeutics HRTX Stock Holding History

Two Sigma Securities’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,136
Closed -$15.8K – 1869
2025
Q4 		$15.8K Buy
+12,136
New +$15K ﹤0.01% 1218
2025
Q3 		– Sell
-14,376
Closed -$29.8K – 1665
2025
Q2 		$29.8K Buy
+14,376
New +$29.4K ﹤0.01% 1155
2022
Q3 		– Sell
-10,685
Closed -$30K – 2813
2022
Q2 		$30K Buy
+10,685
New +$42.9K ﹤0.01% 1904

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Two Sigma Securities's HRTX Position: Q1 2026 in Review

Two Sigma Securities sold out of Heron Therapeutics (HRTX) in Q1 2026, closing a stake of 12,136 shares — an estimated $15.8K sold.

Two Sigma Securities first reported a position in HRTX in Q2 2022 and held it in 3 quarters. The position peaked at $30K in Q2 2022. 167 funds tracked by Wall St. Rank hold HRTX as of Q1 2026.

  • Two Sigma Securities reported no remaining Heron Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 12,136 Heron Therapeutics shares in Q1 2026, an estimated $15.8K.
  • Two Sigma Securities first reported a position in Heron Therapeutics in Q2 2022 and held it in 3 quarters.
  • Two Sigma Securities's Heron Therapeutics position peaked at $30K in Q2 2022.
  • 167 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.